Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine Thieblemont, MD
Centre Hospitalier Lyon Sud, Hematology. Lyon
Study Chair - Emanuele Zucca, MD
International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland. Bellinzona
Study Chair - Emilio Montserrat, MD
Clinic Hospital Universitari, Hematology. Barcelona
Study Chair - Giovanni Martinelli, MD
Hemato-oncology. European Oncology Institute. Milan
Study Chair - Maurizio Martelli, MD
Hematology. Università La Sapienza. Roma
Study Chair - Peter Johnson, MD
Oncology Unit. Southampton General Hospital. Southampton
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
75 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Acza Campus Stuivenberg
Antwerp, Belgium
- Az Stjan
Bruges, Belgium
- St Luc
Brussels, Belgium
- Ulb Hopital Erasme
Brussels, Belgium
- Chndrf
Charleroi, Belgium
- Hospital St Joseph
Gilly, Belgium
- Ucl de Mont Godinne
Yvoir, Belgium
- Centre Hospitalier de Blois
Blois, France
- Hopital Avicenne
Bobigny, France
- Chu
Dijon, France
- Centre Hospitalier
Lens, France
- Chru Lille
Lille, France
- Centre Hospitalier Lyon Sud
Lyon, France
- Centre Leon Berard
Lyon, France
- Institut Paoli Calmettes
Marseille, France
- Hopital Arnold Villeneuve
Monpellier, France
- Chu
Nancy, France
- Chu Hotel Dieu
Nantes, France
- Centre R. Gauducheau
Nantes-St. Herblain, France
- Hopital Henri-Mondor
Paris, France
- Hopital St Louis
Paris, France
- Necker
Paris, France
- Centre Henri Becquerel
Rouen, France
- Spedali Civili
Brescia, Italy
- Azienda Ulss 15 Alta Padovana
Cittadella, Italy
- Ist
Genova, Italy
- Humanitas
Milan, Italy
- Ieo
Milan, Italy
- Int
Milan, Italy
- San Raffaele Hospital
Milan, Italy
- Policlinico
Modena, Italy
- Ospedale Civile
Piacenza, Italy
- A.O. Bianchi-Melacrino-Morelli, Divisione Di Ematologia
Reggio Calabria, Italy
- Arcispedale S. Maria Nuova
Reggio Emilia, Italy
- S. Eugenio
Rome, Italy
- Università Cattolica Sacro Cuore
Rome, Italy
- Università la Sapienza
Rome, Italy
- Sassuolo Gisl
Sassuolo, Italy
- Aou Senese
Siena, Italy
- A.O.U. San Giovanni Battista-Molinette, S.C. Ematologia 2
Torino, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2003
- Primary completion
- 30 Apr 2015
- Completion
- 17 Feb 2016
- Last update posted
- 6 Jun 2019
- Registered enrollment
- 454
- Registry id
- NCT00210353
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.